Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
canakinumab
×
Clear all
Filters
3
NCT03631199
2026-02-25
CANOPY-1
Novartis
Phase 3
Terminated
673 enrolled
38 charts
NCT03626545
2023-08-21
CANOPY-2
Novartis
Phase 3
Terminated
245 enrolled
29 charts